Biotech companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 9 spellings of its name, each linked to the record. See the Johnson & Johnson group view.
As of Nov 14, 2026, FDA's public records list Johnson & Johnson and its 146 subsidiaries with 4,129 510(k) clearances, 1,302 device recalls, 180 drug applications, 12 drug recalls, 3 AI-enabled devices, 3 warning letters, 1 complete response letter and 1 OPDP letter. The most recent is a drug recall dated Sep 23, 2026: IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, F….
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date, Johnson & Johnson and its 146 subsidiaries
A hatched bar is a year that is not over, so its count covers only part of the year.
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
